Distributor Allegedly Failed To Address Suspicious Opioid Orders

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Vet Drug Distributor To Pay $1.125 Million for Failing To Address Suspicious Opioid Orders Adequately

Dennis Tosh

October 31, 2024 at 15:36:35 ET

A veterinary medicine distributor has reached an agreement with the Department of Justice (DOJ) and the DEA under which the company will pay $1.125 million to resolve allegations that it violated Controlled Substances Act requirements for monitoring suspicious orders of opioids, notifying the DEA about significant losses of controlled substances, and reviewing agency information onl... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

Vet Drug Distributor To Pay $1.125 Million for Failing To Address Suspicious Opioid Orders Adequately

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT